D-0571-2025 Class II Ongoing
FDA drug recall D-0571-2025 was initiated by Cardinal Health Inc. on Jul 30, 2025 and is designated Class II. Reason for recall: CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements. The recall status is ongoing. Affected quantity: 6 units.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 13, 2025
- Initiation Date
- Jul 30, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6 units
Product description
Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 9408, NDC: 50242-215-55.
Reason for recall
CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
Distribution pattern
Nationwide Within the U.S.
Code information
Lot: 3617756, Expires: 12/31/2025.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0571-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026